4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-111809
Chief Medical Officer sold 11,442 shares at $3.20 ($36,559)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bedrosian Camille L Chief Medical Officer | 2024-09-30 | Sale | −11,442 | $3.20 | $36,559 | 143,801 | D |
| Open-market sales · 11,442 sh · avg $3.20 · $36,559 | |||||||
Loading xslF345X05/ownership.xml…